Biocodex is an independent multinational pharmaceutical company built on high-standards science and manufacturing, with six decades of proven success. Founded in 1953, the company’s initial focus was gastroenterology featuring a unique probiotic Saccharomyces boulardii CNCM I-745®, the first probiotic drug of its kind that has a positive effect on the gut’s microflora. Today, Biocodex has transformed itself beyond its probiotic drug roots, expanding its portfolio into numerous therapeutic areas which include: Gastroenterology, Pain management, Neurology/Psychiatry, Otolaryngology, Rheumatology. More recently, Biocodex has launched a sport food supplement range : Stimium®.